Supporting the

Neuroendocrine Cancer Community

NETWise – May 2022 Episode

Jun 27, 2022

Most neuroendocrine tumors are low-grade and slow growing, but there are some that are high-grade and very aggressive. These high-grade NETs are treated very differently.
In the May 2022 episode of NETWise, the podcast series by the NET Research Foundation (NETRF), prominent NET experts discuss treatment specifics and challenges of high-grade NETs.
The experts featured in the episode are:
• Dr. Thor Halfdanarson, Medical Oncologist, Mayo Clinic, Minnesota
• Dr. Namrata Vijayvergia, Medical Oncologist, Fox Chase Cancer Center
• Dr. Laura Tang, Pathologist, Memorial Sloan Kettering Cancer Institute
The discussion also covers the perspective of a patient and a caregiver on dealing with the diagnosis. There is also a downloadable transcript of the NETWise episode.